PetVivo Holdings, Inc. (PETV) |
|
2.97 0.03 (1.02%)
|
03-24 16:00 |
|
Open: |
2.967 |
Pre. Close: |
2.94 |
|
High:
|
2.9973 |
Low:
|
2.87 |
|
Volume:
|
20,444 |
Market Cap:
|
32(M) |
|
|
|
Technical analysis |
as of: 2023-03-24 4:28:45 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 3.82 One year: 4.2 |
| Support: |
Support1: 2.74 Support2: 2.27 |
| Resistance: |
Resistance1: 3.27 Resistance2: 3.59 |
| Pivot: |
3.1  |
| Moving Average: |
MA(5): 2.98  MA(20): 3.08
MA(100): 2.55 MA(250): 2.27 |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 24.8 %D(3): 28.3 |
| RSI: |
RSI(14): 49.5 |
| 52-week: |
High: 3.59 Low: 1.23 |
| Average Vol(K): |
3-Month: 35 (K) 10-Days: 46 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ PETV ] has closed above bottom band by 32.1%. Bollinger Bands are 24.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3 - 3.01 |
3.01 - 3.03 |
|
Low:
|
2.84 - 2.85 |
2.85 - 2.87 |
|
Close:
|
2.95 - 2.97 |
2.97 - 2.99 |
|
Company Description |
|
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota. |
Headline News |
Fri, 17 Mar 2023
Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc ... - GlobeNewswire
Fri, 10 Mar 2023
PetVivo Holdings, Inc. to Exhibit and Dr. Erik Kleeman of Ethos ... - GlobeNewswire
Mon, 13 Feb 2023
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE WESTERN ... - GlobeNewswire
Mon, 13 Feb 2023
PetVivo Holdings, Inc. (NASDAQ:PETV) Q3 2023 Earnings Call Transcript - Yahoo Finance
Thu, 26 Jan 2023
PETVIVO HOLDINGS, INC. TO PARTICIPATE IN THE LYTHAM - GlobeNewswire
Mon, 23 Jan 2023
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE 44TH LAKE TAHOE - GlobeNewswire
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
-4 (M) |
| Shares Float |
0 (M) |
|
% Held by Insiders
|
1.073e+007 (%) |
|
% Held by Institutions
|
6.44e+006 (%) |
|
Shares Short
|
0 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-85570 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
-0.63 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-1 |
|
Return on Assets (ttm)
|
938.6 |
|
Return on Equity (ttm)
|
-67.4 |
|
Qtrly Rev. Growth
|
387920 |
|
Gross Profit (p.s.)
|
-0.01 |
|
Sales Per Share
|
0.07 |
|
EBITDA (p.s.)
|
-0.75 |
|
Qtrly Earnings Growth
|
-7.42e+006 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
-4.75 |
|
Price to Sales
|
37.97 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
143070 |
|
Forward Dividend
|
158380 |
|
Dividend Yield
|
4817170% |
|
Dividend Pay Date
|
2020-12-29 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
